Muñoz M, Santaballa A, Seguí M A, Beato C, de la Cruz S, Espinosa J, Fonseca P J, Perez J, Quintanar T, Blasco A
Servicio de Oncología Médica, Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Hospital Clínic de Barcelona, Villarroel, 170-08036, Barcelona, Spain.
Hospital Universitari I Politècnic la Fe, Valencia, Spain.
Clin Transl Oncol. 2016 Dec;18(12):1229-1236. doi: 10.1007/s12094-016-1587-9. Epub 2016 Nov 28.
Chemotherapy and radiotherapy often result in reduced fertility in cancer patients. With increasing survival rates, fertility is an important quality-of-life concern for many young cancer patients. Around 70-75% of young cancer survivors are interested in parenthood but the numbers of patients who access fertility preservation techniques prior to treatment are significantly lower. Moreover, despite existing guidelines, healthcare professionals do not address fertility preservation issues adequately. There is a critical need for improvements in clinical care to ensure patients are well informed about infertility risks and fertility preservation options and to support them in their reproductive decision-making prior to cancer treatment.
化疗和放疗常常会导致癌症患者生育能力下降。随着生存率的提高，生育能力成为许多年轻癌症患者重要的生活质量关注点。大约70%-75%的年轻癌症幸存者对为人父母感兴趣，但在治疗前采用生育力保存技术的患者数量要低得多。此外，尽管有现有指南，但医疗保健专业人员并未充分解决生育力保存问题。迫切需要改善临床护理，以确保患者充分了解不孕风险和生育力保存选择，并在癌症治疗前支持他们做出生殖决策。
